Stock Events

Stock Events

Xtant Medical 

$0.3249
23
-$0.01-2.52% Friday 19:59
+$0.00+0%Friday 23:30After hours

Statistics

Day High
0.3249
Day Low
0.323
52W High
0.95
52W Low
0.27
Volume
1,197
Avg. Volume
-
Mkt Cap
45.58M
P/E Ratio
41.99
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.09
0.03
0.15
0.28
Expected EPS
-0.02
Actual EPS
N/A

Financials

3.71%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
133.93MRevenue
4.97MNet Income

Analyst Ratings

1.00Average Price Target
The highest estimate is 1.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XTNT. It's not an investment recommendation.
NVIDIA
8
NVDA
Alphabet
8
GOOGL
Apple
7
AAPL
Amazon
7
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.83B
Medtronic is a global leader in medical technology, services, and solutions, competing with Xtant Medical in the spinal and orthopedic sector.
Stryker
SYK
Mkt Cap130.11B
Stryker is a top competitor in the medical technology industry, offering a range of products that compete directly with Xtant's offerings in the orthopedic market.
Zimmer Biomet
ZBH
Mkt Cap19.2B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare, directly competing with Xtant Medical in the development and marketing of orthopedic products.
Globus Medical
GMED
Mkt Cap11.53B
Globus Medical, Inc. designs, develops, and commercializes musculoskeletal solutions, competing with Xtant Medical in the spine and orthopedics market.
Boston Scientific
BSX
Mkt Cap75.11B
Boston Scientific Corporation competes with Xtant Medical through its extensive portfolio of medical devices, including those for spinal conditions.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its DePuy Synthes Companies, competes in the orthopedics market, offering products that rival Xtant Medical's.
Alphatec
ATEC
Mkt Cap1.51B
Alphatec Holdings, Inc. designs, develops, and markets spinal fusion technology products and solutions, making it a competitor to Xtant Medical in the spinal health sector.

About

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Show more...
CEO
Sean E. Browne
Employees
151
Country
United States
ISIN
US98420P3082
WKN
000A2JDJS

Listings

F
DE
XMS.F
MU
DE
XMS.MU
STU
DE
XMS.STU
XASE
US
XTNT

0 Comments

Share your thoughts

FAQ

What is Xtant Medical stock price today?▼
The current price of XTNT is $0.32 USD — it has decreased by -2.52% in the past 24 hours. Watch Xtant Medical stock price performance more closely on the chart.
What is Xtant Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Xtant Medical stocks are traded under the ticker XTNT.
Is Xtant Medical stock price growing?▼
XTNT stock has risen by +6.52% compared to the previous week, the month change is a -24.44% fall, over the last year Xtant Medical has showed a -48.83% decrease.
What is Xtant Medical market cap?▼
Today Xtant Medical has the market capitalization of 45.58M
When is the next Xtant Medical earnings date?▼
Xtant Medical is going to release the next earnings report on November 06, 2026.
What were Xtant Medical earnings last quarter?▼
XTNT earnings for the last quarter are -0.07 USD per share, whereas the estimation was -0.02 USD resulting in a -250% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xtant Medical revenue for the last year?▼
Xtant Medical revenue for the last year amounts to 133.93M USD.
What is Xtant Medical net income for the last year?▼
XTNT net income for the last year is 4.97M USD.
How many employees does Xtant Medical have?▼
As of August 23, 2026, the company has 151 employees.
In which sector is Xtant Medical located?▼
Xtant Medical operates in the Health & Wellness sector.
When did Xtant Medical complete a stock split?▼
The last stock split for Xtant Medical was on February 14, 2018 with a ratio of 1:12.
Where is Xtant Medical headquartered?▼
Xtant Medical is headquartered in BELGRADE, United States.